Barnes Alane P bought BCRX
May 13, 2026 · Form 4 insider transaction
Barnes Alane P bought 62,500 shares of BioCryst Pharmaceuticals, Inc. at $5.04 per share, a transaction worth $315.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
62,500
Price
$5.04
Total value
$315.0K
InsiderBarnes Alane P
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 13, 2026
Filing dateMay 15, 2026
Shares owned after463,203
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.